Adult
Conditions
Interventions
NMN-containing supplement, 2 tablets a day, 12 weeks
Sponsors
Research Center for Immunological Analysis, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese females aged 40-60 years at the time of giving informed consent. 2. Individuals who has freely given consent and has understood the purpose of the study. 3. Individuals who can understand and comply with the rules written in protocol during the study period. 4. Individuals who are considered fit for the enrollment in this study.
Exclusion criteria
Exclusion criteria: 1. Individuals who have current or history of food allergies or asthma. 2. Individuals who regularly take medicines that may affect the test. 3. Individuals who regularly take health foods, supplements that may affect the test. 4. Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period. 5. Individuals with a current or history of serious diseases (hepatic, renal, cardiovascular, hematologic, urological, gynecological). 6. Individuals with severe anemia. 7. Individuals who participate in other clinical trials. 8. Individuals judged inappropriate for this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Telomere length | — |
Secondary
| Measure | Time frame |
|---|---|
| SIRT1 mRNA Natural killer cell activity Analysis of wrinkles using VISIA Evaluation of Wrinkle Grade | — |
Countries
Japan
Contacts
Public ContactYoshinori Fujii
NICCA CHEMICAL CO.,LTD. Cosmetics Research Dept.
Outcome results
None listed